دورية أكاديمية
Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial.
العنوان: | Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial. |
---|---|
المؤلفون: | Bryant RA; University of New South Wales, Sydney, New South Wales, Australia.; Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Black Dog Institute, University of New South Wales, Sydney, New South Wales, Australia., Dawson KS; University of New South Wales, Sydney, New South Wales, Australia., Keyan D; University of New South Wales, Sydney, New South Wales, Australia., Azevedo S; University of New South Wales, Sydney, New South Wales, Australia., Yadav S; University of New South Wales, Sydney, New South Wales, Australia., Tran J; University of New South Wales, Sydney, New South Wales, Australia., Rawson N; University of New South Wales, Sydney, New South Wales, Australia., Harvey S; University of New South Wales, Sydney, New South Wales, Australia.; Black Dog Institute, University of New South Wales, Sydney, New South Wales, Australia. |
المصدر: | Psychotherapy and psychosomatics [Psychother Psychosom] 2022; Vol. 91 (1), pp. 63-72. Date of Electronic Publication: 2021 Dec 07. |
نوع المنشور: | Journal Article; Randomized Controlled Trial |
اللغة: | English |
بيانات الدورية: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0024046 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0348 (Electronic) Linking ISSN: 00333190 NLM ISO Abbreviation: Psychother Psychosom Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Basel : Karger |
مواضيع طبية MeSH: | COVID-19*, Adult ; Depression/therapy ; Humans ; Mental Health ; Pandemics ; Psychosocial Intervention ; SARS-CoV-2 ; Single-Blind Method ; Treatment Outcome ; Videoconferencing |
مستخلص: | Introduction: Anxiety and depression have increased markedly during the COVID-19 pandemic. There is a lack of evidence-based strategies to address these mental health needs during the pandemic. Objective: We aim to conduct a proof-of-concept trial of the efficacy of a brief group-based psychological intervention delivered via videoconferencing for adults in Australia distressed by the pandemic. Methods: In this single-blind, parallel, randomised controlled trial, adults who screened positive for COVID-related psychological distress across Australia were randomly allocated to either a 6-session group-based program based on behavioural principles (n = 120) or enhanced usual care (EUC, n = 120). Primary outcome was total score on the Hospital Anxiety and Depression (HADS) anxiety and depression subscales assessed at baseline, 1 week posttreatment, 2 months (primary outcome time point), and 6 months after treatment, as well as secondary outcome measures of worry, sleep impairment, anhedonia, mood, and COVID-19-related stress. Results: Between May 20, 2020, and October 20, 2020, 240 patients were enrolled into the trial. Relative to EUC, at 2 months participants receiving intervention showed greater reduction on anxiety (mean difference, 1.4 [95% CI, 0.3 to 2.6], p = 0.01; effect size, 0.4 [95% CI, 0.1 to 0.7]) and depression (mean difference, 1.6 [95% CI, 0.4 to 2.8], p = 0.009; effect size, 0.4 [95% CI, 0.2 to 0.7]) scales. These effects were maintained at 6 months. There were also greater reductions of worry, anhedonia, COVID-19-related fears, and contamination fears. Conclusions: This trial provides initial evidence that brief group-based behavioural intervention delivered via videoconferencing results in moderate reductions in common psychological problems arising during the COVID-19 pandemic. This program may offer a viable and scalable means to mitigate the rising mental health problems during the pandemic. (The Author(s). Published by S. Karger AG, Basel.) |
References: | Lancet. 2019 Apr 27;393(10182):1733-1744. (PMID: 30948286) Ann Intern Med. 2008 Feb 19;148(4):295-309. (PMID: 18283207) Psychother Psychosom. 2021;90(3):191-199. (PMID: 33212440) BMC Public Health. 2021 Mar 9;21(1):474. (PMID: 33750351) Am J Public Health. 2020 Nov;110(11):1624-1627. (PMID: 32941063) Global Health. 2021 Mar 29;17(1):34. (PMID: 33781283) Psychother Psychosom. 2021;90(2):94-106. (PMID: 32544912) Acta Psychiatr Scand. 1983 Jun;67(6):361-70. (PMID: 6880820) Sleep Med. 2001 Jul;2(4):297-307. (PMID: 11438246) Psychother Psychosom. 2020;89(3):130-132. (PMID: 32213775) Med Care. 2003 May;41(5):582-92. (PMID: 12719681) Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110207. (PMID: 33338558) Occup Med (Lond). 2014 Jul;64(5):393-4. (PMID: 25005549) Psychother Psychosom. 2021;90(3):156-159. (PMID: 33517335) Psychiatry Res. 2020 Aug;290:113117. (PMID: 32480121) Nord J Psychiatry. 2010 Dec;64(6):363-71. (PMID: 20297944) J Clin Psychiatry. 1987 Sep;48(9):366-7. (PMID: 3114242) Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171) JAMA. 2016 Dec 27;316(24):2609-2617. (PMID: 27837602) Annu Rev Psychol. 2001;52:501-25. (PMID: 11148315) PLoS One. 2020 Dec 28;15(12):e0244630. (PMID: 33370404) J Affect Disord. 2020 Mar 15;265:395-401. (PMID: 32090765) Arch Gen Psychiatry. 1983 Jan;40(1):79-84. (PMID: 6849623) J Pers Soc Psychol. 1988 Jun;54(6):1063-70. (PMID: 3397865) J Anxiety Disord. 2020 May;72:102232. (PMID: 32408047) Sci Rep. 2021 May 13;11(1):10173. (PMID: 33986414) J Psychosom Res. 2002 Feb;52(2):69-77. (PMID: 11832252) J Gen Intern Med. 2020 Nov;35(11):3406-3408. (PMID: 32875507) Sleep. 2011 May 01;34(5):601-8. (PMID: 21532953) Prev Med. 2021 Feb;143:106362. (PMID: 33388325) PLoS Med. 2017 Aug 15;14(8):e1002371. (PMID: 28809935) Lancet Psychiatry. 2021 Feb;8(2):121-129. (PMID: 33306975) J Psychosom Res. 2021 Mar;142:110366. (PMID: 33494004) Psychother Psychosom. 2018;87(5):276-284. (PMID: 30007961) J Vestib Res. 2018;27(5-6):295-303. (PMID: 29125530) World Psychiatry. 2015 Oct;14(3):354-7. (PMID: 26407793) |
فهرسة مساهمة: | Keywords: Anxiety; Behaviour therapy; COVID-19; Controlled trial; Depression |
تواريخ الأحداث: | Date Created: 20211207 Date Completed: 20220124 Latest Revision: 20220216 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC8820421 |
DOI: | 10.1159/000520283 |
PMID: | 34875669 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1423-0348 |
---|---|
DOI: | 10.1159/000520283 |